The Cardiologist's Role in the Management of Patients with a Genitourinary Cancer.
Isr Med Assoc J
; 24(3): 175-178, 2022 Mar.
Article
en En
| MEDLINE
| ID: mdl-35347931
ABSTRACT
BACKGROUND:
Increased life expectancy due to improved cancer prognosis, shared determinants (e.g., tobacco use), and cardiovascular toxicities related to cancer therapies, including the adverse cardiometabolic effects of androgen deprivation therapy for prostate cancer, make cardiovascular disease an frequent and important co-morbidity in patients with a genitourinary malignancy. Complex cardiovascular disease can pose significant challenges in the management of these patients given the uncertainties related to the best approach to reconcile ischemic and bleeding risks, and the role of invasive cardiovascular interventions in individuals with advanced cancer. In this review, we discuss the current evidence that informs decision-making in this clinical context.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Próstata
/
Enfermedades Cardiovasculares
/
Neoplasias Urogenitales
/
Cardiólogos
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
Límite:
Humans
/
Male
Idioma:
En
Revista:
Isr Med Assoc J
Asunto de la revista:
MEDICINA
Año:
2022
Tipo del documento:
Article
País de afiliación:
Canadá